TRCT
SBC

Tower Research Capital (TRC)’s SBC Medical Group SBC Stock Holding History

Tower Research Capital (TRC)’s Portfolio SBC Stock Details SBC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12K Sell
3,901
-1,316
-25% -$4.46K ﹤0.01% 3919
2026
Q1 		$21.8K Buy
5,217
+2,827
+118% +$11.8K ﹤0.01% 3423
2025
Q4 		$10.3K Sell
2,390
-439
-16% -$1.68K ﹤0.01% 3800
2025
Q3 		$12.3K Buy
2,829
+2,815
+20,107% +$12.7K ﹤0.01% 3798
2025
Q2 		$65 Buy
+14
New +$55 ﹤0.01% 5178
2025
Q1 		– Sell
-21
Closed -$117 – 5943
2024
Q4 		$117 Hold
21
– – ﹤0.01% 5449
2024
Q3 		$167 Buy
+21
New +$244 ﹤0.01% 5451

Other funds holding SBC

LK
Lumbard & Kellner Hollis, New Hampshire $330M AUM 65.94% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
HIM
Hillsdale Investment Management Toronto, Ontario, Canada $4.39B AUM 72.96% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Tower Research Capital (TRC)'s SBC Position: Q2 2026 in Review

Tower Research Capital (TRC) reduced its SBC Medical Group (SBC) stake by 25% in Q2 2026, selling an estimated $4.46K and leaving 3,901 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #3919.

Tower Research Capital (TRC) first reported a position in SBC in Q3 2024 and has held it in 7 quarters since. The position peaked at $21.8K in Q1 2026. 56 funds tracked by Wall St. Rank hold SBC as of Q2 2026.

  • Tower Research Capital (TRC) held 3,901 shares of SBC Medical Group worth $12K as of Q2 2026.
  • Tower Research Capital (TRC) sold 1,316 SBC Medical Group shares in Q2 2026, an estimated $4.46K.
  • SBC Medical Group made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #3919 holding.
  • Tower Research Capital (TRC) first reported a position in SBC Medical Group in Q3 2024 and has held it in 7 quarters since.
  • Tower Research Capital (TRC)'s SBC Medical Group position peaked at $21.8K in Q1 2026.
  • 56 funds tracked by Wall St. Rank held SBC Medical Group as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.